These final results suggest that the Foxa2 transcription factor binding sequence AGCCTGTTTGCTC (226/214) is the adverse regulatory component of FTO
FTO is highly expressed in the hypothalamus and pancreatic islets, and commonly expressed at a lower degree in multiple tissues including adipose tissue, liver, and skeletal muscle mass. Numerous types…